鳥居薬品の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/06/30 | 6,320 | 6,330 | 6,320 | 6,320 | ±0 | ±0% | 31,400 |
| 2025/06/27 | 6,320 | 6,330 | 6,320 | 6,320 | ±0 | ±0% | 28,400 |
| 2025/06/26 | 6,320 | 6,330 | 6,320 | 6,320 | ±0 | ±0% | 52,100 |
| 2025/06/25 | 6,320 | 6,330 | 6,320 | 6,320 | ±0 | ±0% | 34,300 |
| 2025/06/24 | 6,330 | 6,330 | 6,320 | 6,320 | ±0 | ±0% | 90,900 |
| 2025/06/23 | 6,320 | 6,330 | 6,320 | 6,320 | -10 | -0.2% | 71,000 |
| 2025/06/20 | 6,330 | 6,330 | 6,320 | 6,330 | +10 | +0.2% | 64,300 |
| 2025/06/19 | 6,340 | 6,370 | 6,320 | 6,320 | -20 | -0.3% | 26,300 |
| 2025/06/18 | 6,330 | 6,420 | 6,330 | 6,340 | +10 | +0.2% | 48,400 |
| 2025/06/17 | 6,330 | 6,340 | 6,330 | 6,330 | -10 | -0.2% | 10,800 |
| 2025/06/16 | 6,340 | 6,350 | 6,340 | 6,340 | ±0 | ±0% | 26,100 |
| 2025/06/13 | 6,340 | 6,350 | 6,340 | 6,340 | ±0 | ±0% | 34,200 |
| 2025/06/12 | 6,340 | 6,350 | 6,330 | 6,340 | ±0 | ±0% | 92,500 |
| 2025/06/11 | 6,340 | 6,350 | 6,340 | 6,340 | ±0 | ±0% | 37,300 |
| 2025/06/10 | 6,340 | 6,350 | 6,330 | 6,340 | ±0 | ±0% | 94,300 |
| 2025/06/09 | 6,340 | 6,350 | 6,330 | 6,340 | ±0 | ±0% | 121,000 |
| 2025/06/06 | 6,340 | 6,340 | 6,330 | 6,340 | +10 | +0.2% | 47,900 |
| 2025/06/05 | 6,340 | 6,350 | 6,330 | 6,330 | ±0 | ±0% | 404,600 |
| 2025/06/04 | 6,330 | 6,340 | 6,330 | 6,330 | ±0 | ±0% | 121,000 |
| 2025/06/03 | 6,340 | 6,340 | 6,330 | 6,330 | -10 | -0.2% | 87,700 |
| 2025/06/02 | 6,330 | 6,340 | 6,330 | 6,340 | ±0 | ±0% | 40,800 |
| 2025/05/30 | 6,330 | 6,340 | 6,330 | 6,340 | +10 | +0.2% | 61,300 |
| 2025/05/29 | 6,330 | 6,340 | 6,330 | 6,330 | ±0 | ±0% | 70,000 |
| 2025/05/28 | 6,340 | 6,340 | 6,330 | 6,330 | -10 | -0.2% | 47,900 |
| 2025/05/27 | 6,340 | 6,340 | 6,330 | 6,340 | ±0 | ±0% | 60,000 |
| 2025/05/26 | 6,340 | 6,340 | 6,330 | 6,340 | +10 | +0.2% | 89,900 |
| 2025/05/23 | 6,340 | 6,340 | 6,330 | 6,330 | ±0 | ±0% | 87,200 |
| 2025/05/22 | 6,340 | 6,340 | 6,330 | 6,330 | -10 | -0.2% | 49,800 |
| 2025/05/21 | 6,330 | 6,340 | 6,330 | 6,340 | +10 | +0.2% | 122,800 |
| 2025/05/20 | 6,330 | 6,340 | 6,330 | 6,330 | ±0 | ±0% | 150,200 |
| 2025/05/19 | 6,330 | 6,340 | 6,330 | 6,330 | ±0 | ±0% | 121,700 |
| 2025/05/16 | 6,330 | 6,340 | 6,330 | 6,330 | -10 | -0.2% | 98,000 |
| 2025/05/15 | 6,330 | 6,340 | 6,330 | 6,340 | ±0 | ±0% | 166,700 |
| 2025/05/14 | 6,330 | 6,340 | 6,330 | 6,340 | ±0 | ±0% | 277,000 |
| 2025/05/13 | 6,330 | 6,340 | 6,330 | 6,340 | +10 | +0.2% | 206,400 |
| 2025/05/12 | 6,330 | 6,340 | 6,330 | 6,330 | ±0 | ±0% | 526,000 |
| 2025/05/09 | 6,340 | 6,350 | 6,330 | 6,330 | -10 | -0.2% | 950,900 |
| 2025/05/08 | 6,350 | 6,350 | 6,330 | 6,340 | +760 | +13.6% | 3,056,000 |
| 2025/05/07 | 5,230 | 5,580 | 5,030 | 5,580 | +350 | +6.7% | 670,400 |
| 2025/05/02 | 5,020 | 5,250 | 4,960 | 5,230 | +380 | +7.8% | 564,700 |
| 2025/05/01 | 4,680 | 4,890 | 4,610 | 4,850 | +170 | +3.6% | 317,200 |
| 2025/04/30 | 4,440 | 4,690 | 4,400 | 4,680 | +340 | +7.8% | 315,600 |
| 2025/04/28 | 4,430 | 4,490 | 4,285 | 4,340 | -95 | -2.1% | 263,000 |
| 2025/04/25 | 4,355 | 4,450 | 4,330 | 4,435 | -50 | -1.1% | 258,200 |
| 2025/04/24 | 4,530 | 4,535 | 4,445 | 4,485 | -25 | -0.6% | 94,100 |
| 2025/04/23 | 4,510 | 4,540 | 4,475 | 4,510 | ±0 | ±0% | 104,400 |
| 2025/04/22 | 4,500 | 4,550 | 4,460 | 4,510 | -5 | -0.1% | 112,700 |
| 2025/04/21 | 4,495 | 4,515 | 4,470 | 4,515 | +15 | +0.3% | 103,300 |
| 2025/04/18 | 4,415 | 4,500 | 4,380 | 4,500 | +120 | +2.7% | 113,300 |
| 2025/04/17 | 4,280 | 4,380 | 4,280 | 4,380 | +105 | +2.5% | 101,600 |
1～
50
件表示中 / 3731件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 鳥居薬 | 632,000円 | +7.1% | -35.0% | 0.00% | 52.26倍 | 1.46倍 |
|
ＪＴ傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がＴＯＢ実施 |
| サワイＧＨＤ | 183,300円 | +5.9% | +684.6% | 3.00% | 12.16倍 | 1.22倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| キッセイ薬 | 403,500円 | +3.6% | +6.1% | 2.97% | 13.59倍 | 0.80倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| ジーエヌアイ | 343,500円 | +21.7% | +999.9% | 0.00% | 14.39倍 | 4.76倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| サンバイオ | 240,900円 | - | - | 0.00% | - | 111.58倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
